Biostatistics and Data Management

Allied Technologies and Consulting (ATC) is a Minority and Service-Disabled Veteran-Owned Small Business (SDVOSB) founded in 2001 by two retired Army officers, Intisar Abbasi and Dr. Dale Vander Hamm. ATC is a professional services company serving government and commercial clients in four focus areas: Program Management; Technical & Scientific Services; Information Technology; and Operations, Logistics, & Lifecycle Management.

clinical trial supportConfiguration managementInformation Technologymanagement consultingOperations, Logistics, & Lifecycle ManagementProgram ManagementRegulatory affairsrisk and threat assessmentssupply chain managementTechnical & Scientific Servicesvulnerability assessments

AOTEK LLC is a provider of innovative solutions for the federal government and the private sector in the areas of health, science, and technology. It is a trusted partner of federal prime contractors and provides integrated health mission systems and information services support to the Department of Defense (DoD) and Defense Health Agency (DHA). AOTEK LLC is an SBA-certified Women Owned Small Business (WOSB) and Economically Disadvantaged Women Owned Small Business. AOTEK stands for Alpha and Omega Technologies.

Acquisition Support ServicescGMP/GCP/GLP TrainingClinical Trials Monitoring Supportcommunications and public relationsFDA meetingsFeasibility StudiesFinancial/Budget AssistanceMedical Writing and Documentationperformance metrics and evaluationPolicy developmentProject Management IAW PMBOKquality assurance/quality controlRegulatory affairsregulatory strategyResearch Protocol Designrisk managementstakeholder engagementstrategic planningTelehealth Solutions

AVEO Oncology is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. It operates as an LG Chem company, headquartered in Boston, Massachusetts, and oversees US late-stage clinical development and commercialization of anti-cancer drugs.

clinical developmentcommercialization of oncology therapiesMedical affairs